Aclaris Therapeutics (NASDAQ: ACRS) reported Q4 Revenue for the quarter came in at $9.21 million versus the consensus estimate of $2.08 million.

For earnings history and earnings-related data on Aclaris Therapeutics (ACRS) click here.